Compugen | CGEN - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Arca Biopharma USD 2.23M 1.08M 2025-12
aTyr Pharma USD 635.82K 64.81K 2026-06
Bio Path USD 259K 60K 2026-03
Brainstorm Cell Therapeutics USD 1.21M 178K 2026-03
Cara Therapeutics USD 2.09M 96K 2026-03
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.44M 5K 2026-06
Immunic USD 3.45M 451K 2025-12
Minerva Neurosciences USD 2.48M 58.79K 2024-09
RedHill Biopharma USD 4.48M 1.52M 2024-03
TherapeuticsMD USD 1.23M 90K 2024-06